Drug intelligence / Profile preview

Piper umbellatum

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Piper umbellatum is a tropical and subtropical plant species in the Piperaceae family, widely distributed in Central and South America, Africa, and parts of Asia. It is traditionally used in folk medicine for kidney disorders, diuretic purposes, stomachache, skin disorders, wounds, rheumatism, malaria, inflammation, fever, and women’s reproductive health. Phytochemical constituents include terpenes, sesquiterpenes, monoterpenes (notably linalool, limonene, thymol, β-pinene, α-pinene, camphor), diterpenes, flavonoids, alkaloids, sterols, saponins, tannins, cardiac glycosides, and unique compounds such as 4-nerolidylcatechol, uvangoletin, and wogonin. The plant and its extracts have demonstrated antibacterial, anti-inflammatory, analgesic, antioxidant, cytotoxic, anticancer, antimalarial, antileishmanial, antitrypanosomal, gastroprotective, antifungal, antidiabetic, and insecticidal properties in experimental studies. Its bioactive compounds influence various pathways, notably anti-inflammatory action by inhibition of pro-inflammatory cytokines (such as TNF-α and IL-1β) and oxidative stress markers. Clinical use is mostly as a dietary or herbal remedy, with commercial pharmaceutical development still in early stages[1][2][4][6][7][8][10].

Other names
cow-foot leafPothomorphe umbellataKubambaDa hu jiao
02

Targets

IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Piper umbellatum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piper umbellatum.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call